Phathom Pharmaceuticals Inc (PHAT): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 19,636 US Dollar | 8 | 2 | 2 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 80.900.934 | 12,73 | 6,89 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Phathom Pharmaceuticals Inc
Mitarbeiter 371
Handelsplatz NASDAQ
Ticker Symbol PHAT
IPO Datum 2019-10-25
Adresse 100 Campus Drive, Florham Park, NJ, United States, 07932
Webseite https://www.phathompharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Steven L. Basta M.B.A. | CEO, President & Director |
| 2 | Mr. David A. Socks | Co-Founder |
| 3 | Dr. Azmi Nabulsi M.D., M.P.H. | Co-Founder |
| 4 | Mr. Sanjeev Narula | Chief Financial & Business Officer |
| 5 | Ms. Anne Marie Cook Esq., J.D. | Chief Legal Officer & Corporate Secretary |
| 6 | Mr. Jonathan Bentley | Senior VP and Head of Sales, Operations & Training |
| 7 | Mr. Robert Breedlove | VP of Finance & Principal Accounting Officer |
| 8 | Mr. Eric Sciorilli | Director of Business Development & Investor Relations |
| 9 | Mr. Bill Aprea J.D. | Senior VP, Chief Compliance Officer & Deputy Chief Legal Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 15,41% | 78,29 Mio. USD |
| 2 | Medicxi Ventures Management (Jersey) Ltd | 9,23% | 46,88 Mio. USD |
| 3 | BlackRock Inc | 5,59% | 28,42 Mio. USD |
| 4 | Amvescap Plc. | 4,98% | 25,31 Mio. USD |
| 5 | The Carlyle Group Inc | 4,32% | 21,96 Mio. USD |
| 6 | Millennium Management LLC | 4,17% | 21,20 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 3,28% | 16,69 Mio. USD |
| 8 | GW&K Investment Management, LLC | 2,68% | 13,61 Mio. USD |
| 9 | Franklin Templeton Inc | 2,44% | 12,38 Mio. USD |
| 10 | NEA Management Company, LLC | 2,42% | 12,31 Mio. USD |
| 11 | 683 Capital Management LLC | 2,29% | 11,62 Mio. USD |
| 12 | The Goldman Sachs Group Inc | 2,20% | 11,17 Mio. USD |
| 13 | State Street Corp | 1,96% | 9,96 Mio. USD |
| 14 | Catalys Pacific LLC | 1,85% | 9,38 Mio. USD |
| 15 | Delaware Management Holdings Inc | 1,81% | 9,19 Mio. USD |
| 16 | Geode Capital Management, LLC | 1,63% | 8,26 Mio. USD |
| 17 | Wasatch Advisors LP | 1,62% | 8,21 Mio. USD |
| 18 | Ensign Peak Advisors Inc | 1,30% | 6,61 Mio. USD |
| 19 | Propel Bio Management LLC | 1,30% | 6,60 Mio. USD |
| 20 | Point72 Asset Management, L.P. | 1,26% | 6,42 Mio. USD |